combination therapy Search Results


86
Novartis combination therapies
Combination Therapies, supplied by Novartis, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/10__1182_slash_blood___2023___179529-9-7-21?v=Novartis
Average 86 stars, based on 1 article reviews
combination therapies - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier

95
Chem Impex International clotrimazole
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Clotrimazole, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/bio_rxiv__2023__02__28__530341-173-31-37?v=Chem+Impex+International
Average 95 stars, based on 1 article reviews
clotrimazole - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier

90
Hoechst Marion Roussel tablets of the sequentially combined hormone replacement therapy
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Tablets Of The Sequentially Combined Hormone Replacement Therapy, supplied by Hoechst Marion Roussel, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/pm12472583-36-1-17?v=Hoechst+Marion+Roussel
Average 90 stars, based on 1 article reviews
tablets of the sequentially combined hormone replacement therapy - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
CH Instruments tiotropium/olodaterol combination therapy
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Tiotropium/Olodaterol Combination Therapy, supplied by CH Instruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/10__2147_slash_copd__s246350-65-26-32?v=CH+Instruments
Average 90 stars, based on 1 article reviews
tiotropium/olodaterol combination therapy - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
NanoCarrier Co nanocarrier-based drug combination therapy
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Nanocarrier Based Drug Combination Therapy, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/pm35999629-447-0-0?v=NanoCarrier+Co
Average 90 stars, based on 1 article reviews
nanocarrier-based drug combination therapy - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Zenith Epigenetics combination therapy for the treatment of prostate cancer
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Combination Therapy For The Treatment Of Prostate Cancer, supplied by Zenith Epigenetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/10__1158_slash_1078___0432__ccr___20___4968-255-42-46?v=Zenith+Epigenetics
Average 90 stars, based on 1 article reviews
combination therapy for the treatment of prostate cancer - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
EvaluatePharma ltd npl pd1/pd-l1 combination therapies, 2015
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Npl Pd1/Pd L1 Combination Therapies, 2015, supplied by EvaluatePharma ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/us12259379-8-0-6?v=EvaluatePharma+ltd
Average 90 stars, based on 1 article reviews
npl pd1/pd-l1 combination therapies, 2015 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Institute for Clinical Pharmacodynamics metformin/saxagliptin combination therapy
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Metformin/Saxagliptin Combination Therapy, supplied by Institute for Clinical Pharmacodynamics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/pm21826617-15655-0-33?v=Institute+for+Clinical+Pharmacodynamics
Average 90 stars, based on 1 article reviews
metformin/saxagliptin combination therapy - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
AstraZeneca ltd selumetinib and haart combined therapy
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Selumetinib And Haart Combined Therapy, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/pmc11921695__12885_2025_13890_MOESM1_ESM-192-12-47?v=AstraZeneca+ltd
Average 90 stars, based on 1 article reviews
selumetinib and haart combined therapy - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
NanoCarrier Co hyaluronic acid capped, irinotecan and gene co-loaded lipid-polymer hybrid nanocarrier-based combination therapy platform
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Hyaluronic Acid Capped, Irinotecan And Gene Co Loaded Lipid Polymer Hybrid Nanocarrier Based Combination Therapy Platform, supplied by NanoCarrier Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/10__2147_slash_dddt__s230306-8-20-24?v=NanoCarrier+Co
Average 90 stars, based on 1 article reviews
hyaluronic acid capped, irinotecan and gene co-loaded lipid-polymer hybrid nanocarrier-based combination therapy platform - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Blackwell Verlag combination therapy with ada and acitretin
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Combination Therapy With Ada And Acitretin, supplied by Blackwell Verlag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/pm22934607-253-34-14?v=Blackwell+Verlag
Average 90 stars, based on 1 article reviews
combination therapy with ada and acitretin - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Kalobios Inc combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, <t>clotrimazole,</t> and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.
Combination Antibiotic And Antibody Therapy For The Treatment Of Pseudomonas Aeruginosa Infection, supplied by Kalobios Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/combination+therapy/pmc07410146-187-32-49?v=Kalobios+Inc
Average 90 stars, based on 1 article reviews
combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


(A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.

Journal: bioRxiv

Article Title: Far From Home: Evolution of haploid and diploid populations reveals common, strong, and variable pleiotropic effects in non-home environments

doi: 10.1101/2023.02.28.530341

Figure Lengend Snippet: (A) Lineage tracking data of haploid Bulk Fitness Assay, hBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. Each column represents a replicate. The columns are grouped together by the evolution environment: fluconazole, clotrimazole, glycerol/ethanol. Each row represents the “Test Environment”. Each line represents one lineage evolved in the home environments that corresponds with its column group. The color of the line indicates the test environment in which that lineage was remeasured. (B) Lineage tracking data of diploid Bulk Fitness Assay, dBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol. (C) Lineage tracking data of combined Bulk Fitness Assay, cBFA, for lineages evolved in fluconazole, clotrimazole, and glycerol/ethanol.

Article Snippet: Conditions with 0.2M NaCl (Fisher Scientific - BP358-212), 0.8M NaCl, 21°C, 2% Glycerol (Fisher - G33-4) + 2 % Ethanol (Goldshield - 412804), Fluconazole 13 µM (4 mg/L, Acros Organics #455480050), Clotrimazole 6 µM (or 2 mg/L, Chem-Impex International #01311) were performed with 48 hour transfers at Stanford.

Techniques:

These heatmaps show the fitnesses of all lineages including lineages that had the same mutation and were collapsed into a single row using the median fitnesses in . The number at the end of the name represents numerical barcode identification number. (A) Mutations identified in clotrimazole 1N measured in hBFA, (B) Mutations identified in clotrimazole 2N measured in dBFA, (C) Mutations identified in fluconazole 2N measured in cBFA, (D) Mutations identified in fluconazole 2N measured in dBFA, (E) Mutations identified in glycerol/ethanol 1N measured in hBFA, (F) Mutations identified in glycerol/ethanol 2N measured in cBFA.

Journal: bioRxiv

Article Title: Far From Home: Evolution of haploid and diploid populations reveals common, strong, and variable pleiotropic effects in non-home environments

doi: 10.1101/2023.02.28.530341

Figure Lengend Snippet: These heatmaps show the fitnesses of all lineages including lineages that had the same mutation and were collapsed into a single row using the median fitnesses in . The number at the end of the name represents numerical barcode identification number. (A) Mutations identified in clotrimazole 1N measured in hBFA, (B) Mutations identified in clotrimazole 2N measured in dBFA, (C) Mutations identified in fluconazole 2N measured in cBFA, (D) Mutations identified in fluconazole 2N measured in dBFA, (E) Mutations identified in glycerol/ethanol 1N measured in hBFA, (F) Mutations identified in glycerol/ethanol 2N measured in cBFA.

Article Snippet: Conditions with 0.2M NaCl (Fisher Scientific - BP358-212), 0.8M NaCl, 21°C, 2% Glycerol (Fisher - G33-4) + 2 % Ethanol (Goldshield - 412804), Fluconazole 13 µM (4 mg/L, Acros Organics #455480050), Clotrimazole 6 µM (or 2 mg/L, Chem-Impex International #01311) were performed with 48 hour transfers at Stanford.

Techniques: Mutagenesis

The columns are the home environments that lineages evolved in and the rows are the test environments in which their fitnesses were remeasured. X axis is the fitness of the lineages remeasured in the BFA in their home environment. Y axis is the fitness of the lineages in a non-home environment. No fitness remeasurements are available from BFAs grown in clotrimazole.

Journal: bioRxiv

Article Title: Far From Home: Evolution of haploid and diploid populations reveals common, strong, and variable pleiotropic effects in non-home environments

doi: 10.1101/2023.02.28.530341

Figure Lengend Snippet: The columns are the home environments that lineages evolved in and the rows are the test environments in which their fitnesses were remeasured. X axis is the fitness of the lineages remeasured in the BFA in their home environment. Y axis is the fitness of the lineages in a non-home environment. No fitness remeasurements are available from BFAs grown in clotrimazole.

Article Snippet: Conditions with 0.2M NaCl (Fisher Scientific - BP358-212), 0.8M NaCl, 21°C, 2% Glycerol (Fisher - G33-4) + 2 % Ethanol (Goldshield - 412804), Fluconazole 13 µM (4 mg/L, Acros Organics #455480050), Clotrimazole 6 µM (or 2 mg/L, Chem-Impex International #01311) were performed with 48 hour transfers at Stanford.

Techniques:

Distribution of Fitness Effects for Fitness Estimates of All Adaptive Diploid Lineages remeasured in Clotrimazole, Fluconazole, and Glycerol/Ethanol: The distribution of fitness effects for all adaptive diploid lineages remeasured in clotrimazole, fluconazole, and glycerol/ethanol. The gray vertical line delineates the fitness threshold of the top 10% of mutants that were evolved in the labeled environment. The red line delineated the top fitness of all mutants that were evolved in the labeled environment. The y axis delineates the percentage of mutants that have a specific fitness (x axis).

Journal: bioRxiv

Article Title: Far From Home: Evolution of haploid and diploid populations reveals common, strong, and variable pleiotropic effects in non-home environments

doi: 10.1101/2023.02.28.530341

Figure Lengend Snippet: Distribution of Fitness Effects for Fitness Estimates of All Adaptive Diploid Lineages remeasured in Clotrimazole, Fluconazole, and Glycerol/Ethanol: The distribution of fitness effects for all adaptive diploid lineages remeasured in clotrimazole, fluconazole, and glycerol/ethanol. The gray vertical line delineates the fitness threshold of the top 10% of mutants that were evolved in the labeled environment. The red line delineated the top fitness of all mutants that were evolved in the labeled environment. The y axis delineates the percentage of mutants that have a specific fitness (x axis).

Article Snippet: Conditions with 0.2M NaCl (Fisher Scientific - BP358-212), 0.8M NaCl, 21°C, 2% Glycerol (Fisher - G33-4) + 2 % Ethanol (Goldshield - 412804), Fluconazole 13 µM (4 mg/L, Acros Organics #455480050), Clotrimazole 6 µM (or 2 mg/L, Chem-Impex International #01311) were performed with 48 hour transfers at Stanford.

Techniques: Labeling

Heatmaps Representing Pleiotropic Profiles of Adaptive Mutant Lineages from populations evolved in clotrimazole. Each heatmap shows the lineages evolved in a particular condition and their fitness remeasurements in a specific bulk fitness assay. Each square on the heatmap shows the average fitness of the lineage measured in each environment (columns) for approximately 40 generations, specifically for mutant lineages we identified in (rows). The “+” indicates that in that lineage there are other background mutations, the “++” indicates that this specific mutation was observed in multiple lineages and what is shown in the row is the median fitness of all the lineages that have that mutation. (A) shows the haploids and (B) shows the diploids from the fluconazole evolutions.

Journal: bioRxiv

Article Title: Far From Home: Evolution of haploid and diploid populations reveals common, strong, and variable pleiotropic effects in non-home environments

doi: 10.1101/2023.02.28.530341

Figure Lengend Snippet: Heatmaps Representing Pleiotropic Profiles of Adaptive Mutant Lineages from populations evolved in clotrimazole. Each heatmap shows the lineages evolved in a particular condition and their fitness remeasurements in a specific bulk fitness assay. Each square on the heatmap shows the average fitness of the lineage measured in each environment (columns) for approximately 40 generations, specifically for mutant lineages we identified in (rows). The “+” indicates that in that lineage there are other background mutations, the “++” indicates that this specific mutation was observed in multiple lineages and what is shown in the row is the median fitness of all the lineages that have that mutation. (A) shows the haploids and (B) shows the diploids from the fluconazole evolutions.

Article Snippet: Conditions with 0.2M NaCl (Fisher Scientific - BP358-212), 0.8M NaCl, 21°C, 2% Glycerol (Fisher - G33-4) + 2 % Ethanol (Goldshield - 412804), Fluconazole 13 µM (4 mg/L, Acros Organics #455480050), Clotrimazole 6 µM (or 2 mg/L, Chem-Impex International #01311) were performed with 48 hour transfers at Stanford.

Techniques: Mutagenesis